Scholarlink

<p>Both hypertrophic cardiomyopathy (HCM) and hypertensive heart disease (HHD) are characterized by left ventricular hypertrophy. Distinguishing HCM from HHD is a common clinical problem, particularly in subjects with moderate left ventricular maximal wall thickness (LVMWT) &lt; 18&#xa0;mm. Previously, we showed that cardiac magnetic resonance (CMR)-derived septal convexity (SC) into the left ventricle is increased in subjects with HCM-causing mutations with and without LVH. Our objective now was to determine whether CMR-derived SC differentiates HCM from HHD. We measured the maximal distance between the LV septal endocardial border and a line connecting the proximal and distal septal mid-wall points in 4-chamber images, in subjects with hypertension and LVH (<i>n</i> = 29), in subjects with HCM (<i>n</i> = 49), and in healthy controls (<i>n</i> = 20). Here, we show significantly increased SC in subjects with HCM compared to subjects with HHD both in non-indexed and in BSA-indexed measurements. Cutoff SC values of 7.9&#xa0;mm and 3.7&#xa0;mm/m2 in all HCM patients and SC values of 7.9&#xa0;mm and 3.8&#xa0;mm/m2 in HCM patients with LVMWT &lt; 18&#xa0;mm differentiated between HCM and HHD with good sensitivity and excellent specificity: SC cutoff value of 7.9&#xa0;mm had a sensitivity of 77% and a specificity of 90% in all HCM patients, and 67% and 90% in HCM patients with LVMWT &lt; 18&#xa0;mm, respectively. Our study shows that measuring CMR-derived septal convexity is straightforward and enhances diagnostic performance, providing a novel technique to distinguish between HCM caused by sarcomere mutations and hypertension-induced LVH.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Left ventricular septal convexity in differentiating hypertrophic cardiomyopathy from hypertensive heart disease – a cardiac magnetic resonance study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月5日

查看全文
  • Mika Tarkiainen,
  • Petri Sipola,
  • Mikko Jalanko,
  • Tiina Heliö,
  • Pertti Jääskeläinen,
  • Jarkko Magga,
  • Keijo Peuhkurinen,
  • Minna Husso,
  • Juhana Hakumäki,
  • Mika Laine,
  • Kirsi Lauerma,
  • Johanna Kuusisto

摘要

Both hypertrophic cardiomyopathy (HCM) and hypertensive heart disease (HHD) are characterized by left ventricular hypertrophy. Distinguishing HCM from HHD is a common clinical problem, particularly in subjects with moderate left ventricular maximal wall thickness (LVMWT) < 18 mm. Previously, we showed that cardiac magnetic resonance (CMR)-derived septal convexity (SC) into the left ventricle is increased in subjects with HCM-causing mutations with and without LVH. Our objective now was to determine whether CMR-derived SC differentiates HCM from HHD. We measured the maximal distance between the LV septal endocardial border and a line connecting the proximal and distal septal mid-wall points in 4-chamber images, in subjects with hypertension and LVH (n = 29), in subjects with HCM (n = 49), and in healthy controls (n = 20). Here, we show significantly increased SC in subjects with HCM compared to subjects with HHD both in non-indexed and in BSA-indexed measurements. Cutoff SC values of 7.9 mm and 3.7 mm/m2 in all HCM patients and SC values of 7.9 mm and 3.8 mm/m2 in HCM patients with LVMWT < 18 mm differentiated between HCM and HHD with good sensitivity and excellent specificity: SC cutoff value of 7.9 mm had a sensitivity of 77% and a specificity of 90% in all HCM patients, and 67% and 90% in HCM patients with LVMWT < 18 mm, respectively. Our study shows that measuring CMR-derived septal convexity is straightforward and enhances diagnostic performance, providing a novel technique to distinguish between HCM caused by sarcomere mutations and hypertension-induced LVH.